Swedbank AB lifted its stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 15.5% during the first quarter, Holdings Channel reports. The fund owned 546,659 shares of the real estate investment trust’s stock after acquiring an additional 73,401 shares during the period. Swedbank AB’s holdings in Ventas were worth $44,706,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. GoalVest Advisory LLC purchased a new stake in Ventas during the 4th quarter worth about $26,000. Wiser Advisor Group LLC acquired a new stake in Ventas in the 3rd quarter valued at about $27,000. IFC & Insurance Marketing Inc. purchased a new position in shares of Ventas in the 4th quarter valued at about $30,000. Elyxium Wealth LLC purchased a new position in shares of Ventas in the 4th quarter valued at about $33,000. Finally, Reflection Asset Management acquired a new position in shares of Ventas during the fourth quarter worth about $34,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Ventas Price Performance
Shares of NYSE VTR opened at $92.36 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a fifty-two week low of $62.47 and a fifty-two week high of $94.60. The firm has a market capitalization of $44.90 billion, a PE ratio of 167.94, a price-to-earnings-growth ratio of 2.02 and a beta of 0.70. The stock’s 50-day simple moving average is $86.46 and its 200-day simple moving average is $83.52.
Ventas Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. Ventas’s dividend payout ratio is presently 378.18%.
Insiders Place Their Bets
In related news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.53% of the company’s stock.
Wall Street Analyst Weigh In
VTR has been the topic of several analyst reports. Jefferies Financial Group raised their target price on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Evercore restated an “outperform” rating and issued a $95.00 price objective on shares of Ventas in a report on Wednesday, April 29th. Mizuho set a $98.00 price objective on shares of Ventas in a research report on Friday, May 22nd. Finally, Wells Fargo & Company lifted their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average target price of $96.17.
View Our Latest Research Report on VTR
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
